Stocks Under $10
Good 'Net/Net' Stocks Are Hard to Find
Just five non-biotech names trade below net current asset value.
TG Therapeutics Looks Like a Healthy Play
Small biotech tanked on weak earnings, but still seems promising.
Synergy Pharma Offers Lots of Synergies
I expect Allergan or another player to bid for SGYP soon.
Everybody's Doing It: 5 Stocks Under $10 That I Like
These have positive momentum and good growth.
Homebuilders Back in Play for 2014
The continued growth in housing starts is a good sign for homebuilders in the new year, says Stocks Under $10 Portfolio Manager David Peltier.
Higher Rates Help Regional Banks
Higher interest rates should boost earnings growth for regional banks, says Portfolio Manager David Peltier.
Standard Pacific Appears Oversold
This homebuilder appears oversold, but Portfolio Manager David Peltier likes its exposure to California.
Stocks Under $10: 3 Retail Winner
Low-dollar retail stocks are reaching new highs. Portfolio Manager David Peltier handicaps the sector.
Deconstructing a Housing Stock
Builders FirstSource is a hot low-dollar stock. David Peltier and Lindsey Bell discuss if it's still a buy.
Opportunity Among the Volatility
Volatility has increased at the beginning of earnings season. Portfolio Manager David Peltier says where he find buying opportunities.